FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to a compound of formula I where: R1 represents a group selected from among -CH2OH, -NH(CO)H while R2 represents a hydrogen atom or R1, together with R2, forms group -NH-C(O)-CH=CH- where the nitrogen atom is bonded to the carbon atom in the phenyl ring whereto R1 is bonded, the carbon atom bonded to the carbon atom in the phenyl ring whereto R2 is bonded; R3a and R3b are independently selected from the group consisting of hydrogen atoms and C1-4alkyl groups; X and Y are independently selected from the group consisting of an ordinary bond and an oxygen atom; n, m and q (each) independently have a value selected from among 0, 1, 2 and 3; p has a value selected from among 1, 2 and 3; R4 and R5 are independently selected from the group consisting of hydrogen atoms, a halogen atoms, C1-4alcoxy, -CONH2, -NHCONH2, -SR7, -SO2R7 where R7 represents C3-4cycloalkyl; R6 is selected from the group consisting of hydrogen atoms, a halogen atoms, C1-4 alkyl and C1-4alcoxy or its pharmaceutically acceptable salt or a stereoisomer thereof. Additionally, the invention relates to a pharmaceutical composition based on the compound with formula I and to a method for β2-adrenergic receptor activity modulation.
EFFECT: produced are new 4-(2-amino-1-hydroxiethyl) phenol derivatives possessing the activity of β2-adrenergic receptor antagonists.
22 cl, 32 ex
Title | Year | Author | Number |
---|---|---|---|
4-(2-AMINO-1-HYDROXYETHYL)PHENOL DERIVATIVES AS β2 ADRENERGIC RECEPTOR AGONISTS | 2006 |
|
RU2440330C2 |
ARYLALKYLCARBAMATE DERIVATIVES, SYNTHESIS AND USE THEREOF IN THERAPY | 2004 |
|
RU2400472C2 |
CONJUGATES OF BINDER (ADC) WITH KSP INHIBITORS | 2014 |
|
RU2698697C2 |
2,6,9-TRISUBSTITUTED PURINE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE CATIONIC SALT, METHOD FOR INHIBITION OF CELL PROLIFERATION, PHARMACEUTICAL COMPOSITION | 1997 |
|
RU2220968C2 |
SUBSTITUTED IMIDAZOLES, PHARMACEUTICAL COMPOSITION, METHOD OF TREATING DISEASE, ASSOCIATED WITH, AT LEAST, KSP ACTIVITY AND METHOD OF KSP INHIBITION | 2006 |
|
RU2413721C9 |
PYRROLE- OR IMIDAZOLE AMIDES FOR WEIGHT-REDUCING TREATMENT | 2005 |
|
RU2380367C2 |
PYRIMIDINSULFONAMIDE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS, METHODS OF THEIR OBTAINING (VERSIONS) AND APPLICATION | 2003 |
|
RU2342366C2 |
CATHEPSIN-CYSTEINE PROTEASE INHIBITORS | 2003 |
|
RU2312861C2 |
PYRAZINONE DERIVATIVES AND USE THEREOF IN TREATMENT OF LUNG DISEASES | 2008 |
|
RU2479580C2 |
DERIVATIVES OF 1,2,4-TRIAZOLO[4,3-B]PYRIDO[3,2-D]-PYRIDAZINE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF INHIBITION OF PHOSPHODIESTERASE IV ACTIVITY | 1998 |
|
RU2202552C2 |
Authors
Dates
2012-05-27—Published
2007-10-17—Filed